Amy Praestgaard

2.6k total citations
73 papers, 1.8k citations indexed

About

Amy Praestgaard is a scholar working on Rheumatology, Physiology and Immunology and Allergy. According to data from OpenAlex, Amy Praestgaard has authored 73 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 14 papers in Physiology and 14 papers in Immunology and Allergy. Recurrent topics in Amy Praestgaard's work include Rheumatoid Arthritis Research and Therapies (15 papers), Dermatology and Skin Diseases (13 papers) and Allergic Rhinitis and Sensitization (12 papers). Amy Praestgaard is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Dermatology and Skin Diseases (13 papers) and Allergic Rhinitis and Sensitization (12 papers). Amy Praestgaard collaborates with scholars based in United States, Germany and United Kingdom. Amy Praestgaard's co-authors include Steven M. Kawut, Vinay Nadkarni, Robert A. Berg, David A. Bluemke, João A.C. Lima, R. Graham Barr, Harikrishna Tandri, W. Craig Johnson, Harjit Chahal and Jorge R. Kizer and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Amy Praestgaard

68 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Praestgaard United States	20	518	485	461	346	292	73	1.8k
Joonghyun Ahn South Korea	26	726 1.4×	286 0.6×	538 1.2×	581 1.7×	924 3.2×	139	2.4k
Rajkumar Doshi United States	23	336 0.6×	217 0.4×	786 1.7×	320 0.9×	552 1.9×	179	1.8k
Amirali Masoumi United States	22	344 0.7×	312 0.6×	710 1.5×	155 0.4×	497 1.7×	66	3.1k
Moreno Tresoldi Italy	28	483 0.9×	99 0.2×	622 1.3×	306 0.9×	320 1.1×	79	3.0k
Zongan Liang China	24	933 1.8×	187 0.4×	86 0.2×	453 1.3×	175 0.6×	123	2.1k
Cihan Çevik United States	23	165 0.3×	123 0.3×	1.2k 2.5×	379 1.1×	482 1.7×	98	1.8k
David Inwald United Kingdom	25	387 0.7×	260 0.5×	151 0.3×	678 2.0×	348 1.2×	73	1.9k
Teruhiko Terasawa Japan	20	381 0.7×	415 0.9×	335 0.7×	161 0.5×	526 1.8×	68	2.4k
Jean‐François Légaré Canada	31	634 1.2×	376 0.8×	1.9k 4.1×	292 0.8×	1.2k 4.2×	122	3.2k
Pauline K. Park United States	28	873 1.7×	622 1.3×	292 0.6×	727 2.1×	620 2.1×	61	2.4k

Countries citing papers authored by Amy Praestgaard

Since Specialization

Citations

This map shows the geographic impact of Amy Praestgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Praestgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Praestgaard more than expected).

Fields of papers citing papers by Amy Praestgaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Praestgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Praestgaard. The network helps show where Amy Praestgaard may publish in the future.

Co-authorship network of co-authors of Amy Praestgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Praestgaard. A scholar is included among the top collaborators of Amy Praestgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Praestgaard. Amy Praestgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ständer, Sonja, Andreas Pinter, Patricia Guyot, et al.. (2025). Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison. Dermatology and Therapy. 15(9). 2537–2551. 1 indexed citations

Fokkens, Wytske J., Claus Bachert, Claire Hopkins, et al.. (2024). Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial. Clinical & Translational Immunology. 13(6). e1511–e1511. 2 indexed citations

Curtis, Jeffrey R., Huifeng Yun, Lang Chen, et al.. (2023). Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry. Rheumatology and Therapy. 10(4). 1055–1072. 4 indexed citations

Bachert, Claus, Tanya M. Laidlaw, Seong Cho, et al.. (2023). Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results. Annals of Otology Rhinology & Laryngology. 132(12). 1649–1661. 16 indexed citations

Husain‐Syed, Faeq, Rajat Deo, R. Graham Barr, et al.. (2023). Associations between eGFR and albuminuria with right ventricular measures: the MESA-Right Ventricle study. Clinical Kidney Journal. 16(9). 1508–1520. 3 indexed citations

Flohr, Carsten, Alan D. Irvine, Michael J. Cork, et al.. (2023). Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis. British Journal of Dermatology. 189(2). 238–240. 1 indexed citations

Bachert, Claus, Asif Khan, Stella E. Lee, et al.. (2023). Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐52. International Forum of Allergy & Rhinology. 14(3). 668–678. 15 indexed citations

Máspero, Jorge, Claus Bachert, Fernando J. Martínez, et al.. (2023). Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies. Journal of Asthma and Allergy. Volume 16. 333–342. 3 indexed citations

Busse, William W., Ian Pavord, Shahid Siddiqui, et al.. (2023). Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics. Journal of Asthma and Allergy. Volume 16. 411–419. 13 indexed citations

10.

Berdyshev, Evgeny, Elena Goleva, Robert Bissonnette, et al.. (2022). Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis. Allergy. 77(11). 3388–3397. 77 indexed citations

11.

Rubbert‐Roth, Andrea, Daniel E. Fürst, Stefano Fiore, et al.. (2022). Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab. Arthritis Research & Therapy. 24(1). 207–207. 4 indexed citations

12.

Bachert, Claus, Asif Khan, Claire Hopkins, et al.. (2022). Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP. Journal of Asthma and Allergy. Volume 15. 557–563. 10 indexed citations

13.

Burmester, Gerd R, Vivian P. Bykerk, Maya H Buch, et al.. (2021). Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis. Lara D. Veeken. 61(6). 2596–2602. 6 indexed citations

14.

Genovese, Mark C., Gerd R Burmester, Laure Gossec, et al.. (2020). THU0167 ASSOCIATIONS BETWEEN RHEUMATOID ARTHRITIS DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN SARILUMAB CLINICAL TRIALS. Annals of the Rheumatic Diseases. 79. 299–299.

15.

Rhee, Rennie L., et al.. (2015). Comparison of Treatment Response in Idiopathic and Connective Tissue Disease–associated Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 192(9). 1111–1117. 73 indexed citations

16.

Donoghue, Aaron, Benjamin S. Abella, Raina M. Merchant, et al.. (2015). Cardiopulmonary resuscitation for in-hospital events in the emergency department: A comparison of adult and pediatric outcomes and care processes. Resuscitation. 92. 94–100. 28 indexed citations

17.

Whitman, Isaac R., Vickas V. Patel, Elsayed Z. Soliman, et al.. (2013). Validity of the Surface Electrocardiogram Criteria for Right Ventricular Hypertrophy. Journal of the American College of Cardiology. 63(7). 672–681. 27 indexed citations

18.

Larkin, Gregory Luke, R. Scott Braithwaite, T. Michael Kashner, et al.. (2008). NATIONAL REGISTRY OF CARDIOPULMONARY RESUSCITATION INVESTIGATORS. SURVIVAL FROM IN-HOSPITAL CARDIAC ARREST DURING NIGHTS AND WEEKENDS. 299(7). 785–792. 59 indexed citations

19.

Hecker, James G., Shaomin Zou, Amy Praestgaard, et al.. (2008). Heat shock proteins HSP70 and HSP27 in the cerebral spinal fluid of patients undergoing thoracic aneurysm repair correlate with the probability of postoperative paralysis. Cell Stress and Chaperones. 13(4). 435–446. 17 indexed citations

20.

Valenstein, Paul N., et al.. (2001). Six-year trends in productivity and utilization of 73 clinical laboratories: a College of American Pathologists Laboratory Management Index Program study.. Archives of Pathology & Laboratory Medicine. 125(9). 1153–61. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact